Skip to main content
OpenTrials

Clinical trial condition

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Explore clinical trials studying Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) trial results

Enrolling by Invitation

An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

NCT05667493

Conditions
Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +2 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Beverly Hills, California, United States
  • Altman Clinical and Translational Research Institute - Center for Clinical Research La Jolla, California, United States
  • University Of California San Francisco Urology Practice San Francisco, California, United States
View all 134 locations
View Trial Details
Active, Not Recruiting

CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

NCT04136171

Conditions
Amyloidosis, Cardiomyopathies, Cardiovascular Diseases, +5 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Altman Clinical and Translational Research Institute Center for Clinical Research La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) - Medical Center San Francisco, California, United States
View all 142 locations
View Trial Details

Related conditions